Purpose: The revised prescription drug labeling developed by the Food and Drug Administration (FDA) is described. Summary: A new FDA final rule, "Requirements on Content and Format of Labeling for ...

Renu Lal, Pharm.D., is Scientist, Genentech, Inc.; when this article was written she was Team Leader, Division of Drug Information, Office of Training and Communications, Center for Drug ...

Additional packages of clonazepam, a prescription medication used to treat seizures and anxiety, mislabeled with the ...

Food and Drug Administration (FDA) announces important safety label changes for prescription drugs almost every month. By implementing the label changes the FDA warns a physician of new side ...

An anxiety drug is being voluntarily recalled over a mislabeling error that could be “possibly life-threatening," according ...

A widely used anxiety medication taken by nearly 2 million Americans is being recalled nationwide due to a 'life-threatening' ...

New York–based drug giant Pfizer is paying $2.3 billion to settle claims of off-label promotion of four of its drugs, including the cyclooxygenase 2 (COX-2) inhibitor Bextra (valdecoxib), the US ...

Clonazepam, an anxiety drug, has been recalled because of a labeling error that could result in harmful consequences.

The FDA has approved updated drug labeling for Sandoz in the treatment of B-cell chronic lymphocytic leukemia.

the drug's manufacturer. Endo originally issued ... "Our own quality investigation identified a potential label inaccuracy at a third-party vendor, leading to this expanded recall of to a limited ...